We found that PD-L1 and PD-1 positive tumors had more CD8+ (cytotoxic T cells), CD20+ (B-lymphocytes), and FoxP3+ (Tregs) cells than PD-L1 and PD-1 negative IBC tumors. This evidence concerns the gene PDCD1 and inflammatory breast carcinoma.